| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2016: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2015: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2014: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
|---|
| Outline of Final Research Achievements |
To eluciate the efficacy and safety the eraly pharmacological intervention for the borderline pulmonary arterial hypertension associated with connective tissue disease, we examined the hemodynamic parameters in pre- and follow-up period under exercise with right heart catheterization between treatment group and non-treatment group. Progression of abnormal response in exercise was observed in non-treatment group but not in treatment group. In conclusion, early pharmacological intervention might be safe and effective for patients with borderline pulmonary arterial hypertension to prevent pulmonary vascular remodeling.
|
